The table below shows Edwards Lifesciences Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$6.07B
$5.44B
$5.01B
$4.46B
$5.23B
$4.39B
Cost of revenue
$1.33B
$1.12B
$978.40M
$723.70M
$1.25B
$1.08B
Gross profit
$4.73B
$4.32B
$4.03B
$3.74B
$3.98B
$3.31B
R&D
$1.08B
$1.05B
$962.90M
$843.60M
$903.10M
$760.70M
SG&A
EW annual revenue (10-K history)
Edwards Lifesciences Corp reported annual revenue of $6.07B for fiscal year 2025. That is up 11.5% from $5.44B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.96B (FY 2016) to $6.07B. Figures come from the company's audited annual reports as filed with the SEC.
